Technical Feasibility and Performance of the Sensor SystemNCT07908173
Magnetic Field Maps With NV Application Kit MCG
An observational study of Technical Feasibility and Performance of the Sensor System and Healthy Adult, run by Bosch Quantum Sensing GmbH.
Trial summary
This prospective, single-center, exploratory feasibility study investigates the use of diamond-based nitrogen-vacancy (NV) magnetometers for non-invasive magnetocardiography (MCG). Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Technical Feasibility and Performance of the Sensor System, Healthy Adult, Healthy Adult Participants
- What is being tested?
- Contactless measurement of cardiac magnetic field.
- How many people
- 12 participants
- Where
- No sites listed yet
- Study dates
- 23 Oct 2026to 30 May 2028
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: The study population consists of healthy adult volunteers recruited from employees of Robert Bosch GmbH (Corporate Research and Advanced Engineering) and Bosch Quantum Sensing GmbH.
Who may be able to join
- Age ≥18 years.|
- Employee of Robert Bosch GmbH or Bosch Quantum Sensing GmbH.|
- Able to provide written informed consent.|
- Able to comply with study procedures.|
- No acute physical or mental impairment.|
- No known cardiac disease.|
- Legally competent and capable of self-care.|
Who cannot join
- Pregnancy|
- Known cardiac, neurological, or psychiatric disease.|
- Claustrophobia or agoraphobia.|
- Known cardiac arrhythmias.|
- Metallic implants, metallic prostheses, or cardiac pacemaker.|
- Inability to remain still in the supine position for several minutes.|
- Body weight >99 kg.|
- Withdrawal of informed consent.|
Trial locations and contacts
No sites are listed yet. Contact the study team or a site near you to ask about taking part.
About this study
This prospective, single-center, exploratory feasibility study investigates the use of diamond-based nitrogen-vacancy (NV) magnetometers for non-invasive magnetocardiography (MCG). The goal is to assess whether highly sensitive NV sensors can reliably detect and reconstruct the weak magnetic fields generated by the human heart and evaluate their potential for future cardiac diagnostics.
- Conditions
- Technical Feasibility and Performance of the Sensor System, Healthy Adult, Healthy Adult Participants
- Being tested
- Contactless measurement of cardiac magnetic field.
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Contactless measurement of cardiac magnetic field.Diagnostic test
Participants will undergo non-invasive cardiac magnetic field measurements using an array of diamond nitrogen-vacancy (NV) magnetometers.
What is being measured
The primary outcome is the main question the study is designed to answer.
Reconstruction of Cardiac Magnetic Field Maps
- Are the magnetic field signals (on the basis of the single sensor) recorded with the NV Application Kit in accordance with literature in terms of amplitude (in pT) and duration (in ms) of the p-wave, QRS-complex, T-wave?
- Are the magnetic field maps recorded with the NV Application Kit in accordance with literature in terms of the number, location, and amplitude of magnetic poles?
Measured: up to two weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted30 Oct 2026
- Study start23 Oct 2026 (estimated)
- Primary completion28 Feb 2028 (estimated)
- Study completion30 May 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Technical Feasibility and Performance of the Sensor SystemStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 12 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Bosch Quantum Sensing GmbH
- Sponsor type
- Industry (pharma, biotech, devices)
- Collaborators
- Robert Bosch GmbH
- Responsible party
- Principal investigator, Eckhard Wehrse, Robert Bosch GmbH
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07908173
- Sponsor's protocol ID
- 0000510017
- Status last verified
- Oct 2026
- First submitted
- 19 Oct 2026
- Last updated
- 30 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 30 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Magnetic Field Maps With NV Application Kit MCG
- ClinicalTrials.gov ID
- NCT07908173
- Acronym / sponsor ID
- 0000510017
- Conditions
- Technical Feasibility and Performance of the Sensor System, Healthy Adult, Healthy Adult Participants
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 12 participants (estimated)
- Lead sponsor
- Bosch Quantum Sensing GmbHIndustry (pharma, biotech, devices)
- Collaborators
- Robert Bosch GmbH
- Study start
- 23 Oct 2026 (estimated)
- Primary completion
- 28 Feb 2028 (estimated)
- Study completion
- 30 May 2028 (estimated)
- First posted
- 30 Oct 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This prospective, single-center, exploratory feasibility study investigates the use of diamond-based nitrogen-vacancy (NV) magnetometers for non-invasive magnetocardiography (MCG). The goal is to assess whether highly sensitive NV sensors can reliably detect and reconstruct the weak magnetic fields generated by the human heart and evaluate their potential for future cardiac diagnostics.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- The study population consists of healthy adult volunteers recruited from employees of Robert Bosch GmbH (Corporate Research and Advanced Engineering) and Bosch Quantum Sensing GmbH.
Key inclusion criteria (7 listed)
- Age ≥18 years.|
- Employee of Robert Bosch GmbH or Bosch Quantum Sensing GmbH.|
- Able to provide written informed consent.|
- Able to comply with study procedures.|
- No acute physical or mental impairment.|
Key exclusion criteria (8 listed)
- Pregnancy|
- Known cardiac, neurological, or psychiatric disease.|
- Claustrophobia or agoraphobia.|
- Known cardiac arrhythmias.|
- Metallic implants, metallic prostheses, or cardiac pacemaker.|
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Contactless measurement of cardiac magnetic field.Participants will undergo non-invasive cardiac magnetic field measurements using an array of diamond nitrogen-vacancy (NV) magnetometers. | Diagnostic test | – |
Primary outcome
Reconstruction of Cardiac Magnetic Field Maps
Time frame: up to two weeks
* Are the magnetic field signals (on the basis of the single sensor) recorded with the NV Application Kit in accordance with literature in terms of amplitude (in pT) and duration (in ms) of the p-wave, QRS-complex, T-wave? * Are the magnetic field maps recorded with the NV Application Kit in accordance with literature in terms of the number, location, and amplitude of magnetic poles?
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 30 Oct 2026.
- Individual participant dataSharing planned: Undecided
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Questions about this trial
What is this clinical trial studying?
An observational study of Technical Feasibility and Performance of the Sensor System and Healthy Adult, run by Bosch Quantum Sensing GmbH.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 30 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Eckhard Wehrse, MD (+4971181129440, eckhard.wehrse@de.bosch.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Reconstruction of Cardiac Magnetic Field Maps (time frame: up to two weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Oct 2026.